Detoxification From the Lipid Tract
Conditions: COVID-19 Vaccine Adverse Reaction Interventions: Device: electroencephalogram biofeedback; Device: electrical brain stimulation; Device: ultra-low frequency transcranial magnetic stimulation; Drug: Sertraline Hydrochloride; Drug: Clonazepam; Drug: Alprazolam; Drug: Metoprolol; Drug: Olanzapine; Drug: Pravastatin Sodium 20 MG; Drug: Sacubitril Valsartan Sodium Hydrate Sponsors: Pachankis, Yang I., M.D.; First Affiliated Hospital of Chongqing Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Initial treatment with a single capsule containing half-dose quadruple therapy versus standard-dose dual therapy in hypertensive patients (QUADUAL): statistical analysis plan for a randomized, blinded, crossover trial
DiscussionThis statistical analysis plan will be confirmed prior to blind review and data lock before un-blinding and is sought to increase the validity of the QUADUAL trial.Trial registrationClinicalTrials.gov, NCT05377203. Registered May 11, 2022,https://clinicaltrials.gov/study/NCT05377203. (Source: Trials)
Source: Trials - January 13, 2024 Category: Research Source Type: clinical trials
Determination of Drug Levels for Pharmacotherapy of Heart Failure
Conditions: Cardiovascular Diseases; Heart Failure With Reduced Ejection Fraction Interventions: Drug: Nebivolol; Drug: Valsartan and Sacubitril; Drug: Carvedilol; Drug: Bisoprolol; Drug: Metoprolol; Drug: Spironolactone Sponsor: University Hospital Ostrava Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis
Condition: Atopic Dermatitis Interventions: Dietary Supplement: Caffeine; Drug: Metoprolol; Drug: Midazolam; Drug: Warfarin; Dietary Supplement: Vitamin K; Drug: Omeprazole; Drug: Rocatinlimab Sponsor: Amgen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 6, 2023 Category: Research Source Type: clinical trials
